Hypertension is the most common condition in the United States, and current guidelines for hypertension treatment recommend adoption of the Dietary Approaches to Stop Hypertension (DASH) diet to lower high blood pressure (BP). [1] [2] [3] The DASH diet, a diet rich in fruits, vegetables, lowfat dairy, and low in saturated and total fat content, lowers systolic BP by 11.4 mm Hg and diastolic BP by 5.5 mm Hg in adults with hypertension. 4 Combining the DASH diet with reduced sodium intake has a greater effect than either intervention alone, 5 an effect equal to or greater than that of singledrug therapy. 6 The DASH diet has also been associated with reduced metabolic risks in both men and women. 7 Results in practice settings have been mixed, both for BP and long-term outcomes. Both the Women's Health Initiative Dietary Modification Trial and the PREMIER trial demonstrated only modest BP-lowering effects of healthful dietary interventions in freely eating participants. 8, 9 Although the Women's Health Initiative did not demonstrate a reduction in risk of cardiovascular disease (CVD) and stroke in postmenopausal women, 8 recent findings from the Nurses' Health Study demonstrated a decreased risk of CVD and stroke in middle-aged female nurses who consumed a DASH-like diet. 10 Recent data from the Iowa Women's Health Study did not demonstrate an association between consumption of a DASH-like diet and incidence of hypertension or mortality from CVD and stroke in nonhypertensive women. 11 Thus, the impact of the DASH diet on mortality remains unclear.
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It has been hypothesized that the benefits of the DASH diet may extend beyond known cardiovascular effects. 12 Although there are studies examining the association between the DASH diet and cardiovascular risk, data on the association between the DASH diet and all-cause as well as other specific causes of mortality are limited. We therefore evaluated whether a DASH-like diet is associated with lower all-cause and cause-specific mortality in a nationally representative sample of adults with hypertension.
methodS
Survey design and population. This is a prospective cohort study of adults with hypertension in the Third National Health and articles
A DASH-Like Diet and Mortality in Hypertension
Nutrition Examination Survey (NHANES III). 13 Baseline data were collected from 1988 to 1994 as a cross-sectional, complex, multi-stage survey of a representative sample of the US civilian noninstitutionalized population. NHANES III oversampled non-Hispanic blacks, Mexican Americans, and persons over age 60 to obtain reliable information about these subgroups. Individuals aged ≥17 (n = 20,050) received a home-based interview; 17,705 of these participants were examined in the mobile examination center (MEC). Follow-up on vital status and cause of death were obtained from the NHANES III Linked Mortality File, which linked participants to information obtained from National Death Index death certificate data. 14 Responses to demographic, lifestyle, dietary, and medical history questions were gathered by trained professionals. During the MEC exam, a physical exam was performed and blood was drawn. Dietary intake data came from a 24-h dietary recall administered by trained bilingual interviewers using the NHANES III Dietary Data Collection System, 15 an automated, microcomputer-based dietary interview and coding system with built-in probes to optimize dietary recall quality. The primary source of food composition data was the US Department of Agriculture Survey Nutrient Database. 16 The National Center for Health Statistics determined the completeness and reliability of dietary recall, with verification of extreme values.
We included participants ≥17 years of age with complete and reliable dietary recall data and recognized or unrecognized hypertension. We defined hypertension by: (i) a participant self-reporting being told at least twice by a health care professional of the diagnosis, (ii) reported antihypertensive medication use, or (iii) mean systolic BP ≥140 mm Hg or mean diastolic BP ≥90 mm Hg. BP was measured using a mercury sphygmomanometer, with multiple measurements obtained during the interview by a trained interviewer and during the MEC exam by a physician.
Dietary variables.
From the 24-h dietary recall, we obtained information on intake of total calories (kcal), fiber (g), cholesterol (mg), calcium (mg), magnesium (mg), sodium (mg), and potassium (mg), as well as the percentage of total energy from fats, saturated fats, monounsaturated fats, polyunsaturated fats, proteins, carbohydrates, and alcohol. In addition, we obtained data on total daily servings of food groups such as grains, fruits and vegetables, dairy, meat, and legumes.
To define DASH-like diet consumers, we first calculated the population means of nine micro-and macronutrients suggested by the DASH and PREMIER investigators. 17 We then constructed a nine-point composite scale using a method adapted from Mellen et al. 18 We added one point each for reaching the DASH-recommended target level for a nutrient and a half-point each for reaching an intermediate target halfway between the population mean and the DASH target for that nutrient ( Table 1) . Participants less than halfway between the population mean and the DASH target for the nutrient were assigned a score of zero. The points for each participant were summed and participants who scored ≥5 were classified as DASH-like consumers; participants scoring <5 were classified as typical diet consumers. Our scoring system differed from Mellen et al. in that we used population means rather than nutrient levels chosen for the control diet in the DASH trial. 4 The control diet in the DASH trial was a diet deliberately designed to be deficient in potassium, calcium, magnesium, and bicarbonate precursors. 19 By using population means rather than the control diet values to establish the comparison group, we sought to better reflect the typical diet of the average hypertensive adult during the time of NHANES III data collection. Based on the population mean of total caloric intake for the entire cohort, the DASH targets used were those recommended for a 2,000 kcal/day diet. 17 Sample demographics, cardiovascular risk factors, and comorbid conditions. We obtained information on age, gender, race-ethnicity, education, and income from the NHANES III household adult survey data. Race-ethnicity was obtained by self-report and classified as non-Hispanic white, non-Hispanic black, Mexican American, and other. Education was categorized as did not complete high school, completed high school only, or obtained at least some level of higher education. Poverty income ratio, the ratio between the midpoint of the observed family income category (<$10,000, $10,000-29,999, $30,000-49,999, and ≥$50,000) and the poverty threshold produced annually by the Census Bureau, allowed income to be analyzed uniformly across the entire survey period. Smoking status was dichotomized as current smokers and former or never smokers. Body mass index (BMI) was calculated from height and weight measured at the MEC examination and dichotomized into obese (BMI ≥30 kg/m 2 ) and nonobese (BMI <30 kg/m 2 ). 20 ªThe DASH targets used in this study were based on a 2,000 kcal/day diet; 17 this was in turn based on the population mean for the entire cohort. Participants reaching the target level of a nutrient were assigned one point for that nutrient, those reaching an intermediate target at least halfway between the DASH target and the population mean were assigned a half-point for that nutrient. The points were then summed; participants scoring a total of at least five out of a possible nine points were assigned to the DASHlike diet group, while those scoring <5 were assigned to the typical diet group. b All population means are reported using survey weights, strata, and cluster variables to obtain population estimates. c Sodium target based on current guidelines. 1 d Total fat, saturated fat, and protein targets are presented as the percentage of total energy intake.
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Total cholesterol (mg/dl), triglycerides (mg/dl), high-density lipoprotein (mg/dl), C-reactive protein (CRP, mg/dl), fibrinogen (mg/dl), and glycated hemoglobin (percentage of total hemoglobin) values were obtained from blood collected during the MEC examination using methods described by the US Department of Health and Human Services. 22 Hyperlipidemia was defined by self-reported high cholesterol, self-reported cholesterol-lowering medication use, or total cholesterol ≥200 mg/dl. Diagnoses of comorbid conditions such as diabetes, myocardial infarction (MI), stroke, and congestive heart failure were obtained by self-report.
Outcome variables. Person-months of follow-up from the MEC examination date were obtained from the Linked Mortality File. Mortality follow-up was complete through 31 December 2000. Our primary outcome was all-cause mortality, defined by the final determination of vital status by the National Center for Health Statistics using a probabilistic match between NHANES III and National Death Index death certificate data. 23 Secondary outcomes included mortality from CVD, ischemic heart disease (IHD), stroke, and cancer; these were determined from the death certificate data by pooling cause of death codes from the 10th revision of the International Classification of Diseases, Injuries, and Causes of Death (ICD-10) (ref. 24) . CVD mortality included all cardiovascular death codes (ICD-10 codes I00-I78). IHD mortality included a subset of CVD codes that incorporated unstable angina, acute MI, complications following acute MI, and chronic IHD (I20-I25). Stroke mortality included a subset of CVD codes that incorporated cerebrovascular diseases such as subarachnoid hemorrhage, intracerebral hemorrhage, intracranial hemorrhage, and cerebral infarction (I60-69). Cancer mortality included malignant neoplasms (C00-C97) as well as in situ neoplasms, benign neoplasms, and neoplasms of uncertain or unknown behavior (D00-D48).
Statistical analysis. Baseline characteristics, nutrient intakes, and food group servings were compared between typical and DASHlike consumers using survey procedures in SAS 9.1 (Statistical Analysis System, Cary, NC). 25 Unadjusted all-cause and causespecific mortality rates stratified by the dichotomous diet variable were obtained by a life table product limit method. All-cause Kaplan-Meier curves were determined for the dichotomous diet variable and the equality of curves was tested by a log-rank statistic. To evaluate the independent effect of a DASH-like diet on mortality, we fit age-and sex-adjusted Cox proportional hazards models followed by multivariate models adjusting for raceethnicity, education, income, smoking status, obesity, physical activity, BP, hyperlipidemia, CRP, diabetes, MI, stroke, and congestive heart failure. Further, because statistical adjustment of these covariates in the model may not be sufficient to exclude potential confounders, we formally tested each of the model covariates for interaction with diet status. Two-sided P values <0.05 were considered significant. All analyses accounted for the complex survey design by utilizing survey weight, strata, and cluster variables to obtain population estimates. 
reSultS
Of the 5,532 participants with hypertension, 391 (7.1%) consumed a DASH-like diet and 5,141 (92.9%) consumed a typical diet. The DASH-like consumers were older, included more non-Hispanic whites, had higher poverty income ratios (signifying higher incomes), higher education, more physical activity, lower BMI, and lower diastolic BP than the typical group ( Table 2) . There were proportionally more men and diabetics in the DASH-like group, though not statistically significant, and hemoglobin A 1c levels did not differ between groups.
More of the DASH-like consumers had hyperlipidemia than the typical diet consumers, but total levels of cholesterol, high-density lipoprotein, and triglycerides did not significantly differ. CRP was significantly lower in the DASH-like group. Fibrinogen was lower in the DASH-like group, though this did not reach statistical significance. Prior diagnoses of MI, stroke, and congestive heart failure did not significantly differ between groups.
Compared to the typical group, the DASH-like group had higher total caloric, fiber, calcium, magnesium, and potassium intake, and lower cholesterol intake ( Table 3) . Sodium and alcohol intake did not differ significantly. The DASH-like group consumed a lower percentage of total fat, saturated fat, monounsaturated fat, and polyunsaturated fat, while consuming a higher percentage of carbohydrate and protein. The DASH-like group consumed more servings of grains, fruits and vegetables, dairy, and legumes. Meat intake did not differ between groups.
There were a total of 1,537 all-cause deaths. This included 312 cancer deaths and 788 cardiovascular deaths, of which 447 were due to IHD and 142 were due to stroke ( Table 4) . Average follow-up time was 8.2 person-years. The DASHlike group had lower unadjusted mortality rates per 1,000 person-years of follow-up for all-cause mortality (P = 0.02), stroke mortality (P < 0.001), and cancer mortality (P = 0.05). Unadjusted mortality rates for CVD and IHD were lower in the DASH-like group, but the differences were not statistically significant. a All-cause and cause-specific deaths are presented as the total number of deaths as well as the percentage of participants deceased on follow-up, stratified by diet. There were 1,537 all-cause deaths; this included 312 cancer deaths and 788 cardiovascular deaths, of which 447 were due to ischemic heart disease and 142 were due to stroke. b Population estimates of the percentage of participants deceased on follow-up are reported using survey weights, strata, and cluster variables. 95% confidence intervals for these population estimates are given in brackets. c Mortality rates per 1,000 person-years of follow-up are presented unadjusted for confounders. Data is reported as population estimates using survey weights, strata, and cluster variables.
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To determine whether time to death differed between the groups, we compared unadjusted Kaplan-Meier curves for those consuming a typical diet and those consuming a DASHlike diet (Figure 1) . We found lower all-cause mortality in the DASH group compared to the typical group (P = 0.02 from log-rank statistic), with divergence between the groups at ~50 months of follow-up.
To further evaluate the association between diet and mortality while controlling for important confounders, Cox proportional hazards models were used. The results were similar across initial, intermediate, and final models. In initial ageand sex-adjusted models (Figure 2) , a DASH-like diet was associated with lower mortality from all causes, stroke, and cancer. Risk of mortality from CVD and IHD did not reach statistical significance. In the final models adjusted for age, sex, race, education, income, physical activity, obesity, smoking, BP, hyperlipidemia, CRP, diabetes, MI, stroke, and congestive heart failure (Figure 3) , the DASH-like diet was associated with lower mortality from all causes (hazard raio (HR) 0.69, 95% confidence interval (CI) 0.52-0.92, P = 0.01) and stroke (HR 0.11, 95% CI 0.03-0.47, P = 0.003). Mortality from CVD (HR 0.92, 95% CI 0.63-1.35, P = 0.67), IHD (HR 0.77, 95% CI 0.47-1.14, P = 0.28), and cancer (HR 0.51, 95% CI 0.23-1.10, P = 0.09) did not reach statistical significance.
To assess whether the effect of diet on mortality varied at different levels of certain covariates (BMI, diastolic BP, hyperlipidemia, and CRP), we tested interaction terms between diet and each of these covariates using separate multivariate models. The P values for the interactions were: 0.15 for diet × BMI, 0.74 for diet × diastolic BP, 0.92 for diet × hyperlipidemia, and 0.10 for diet × CRP.
diScuSSion
This population-based analysis reemphasizes the importance of a healthful diet in adults with hypertension and demonstrates an association between a DASH-like diet and lower all-cause mortality. It also provides evidence that a DASHlike diet may be associated with lower cause-specific mortality in adults with hypertension, notably stroke mortality. Though the HR point estimates indicate potential associations between a DASH-like diet and both CVD and IHD mortality, these results did not reach statistical significance. A statistically significant association with lower cancer mortality was All-cause* CVD IHD Stroke* Cancer* Figure 2 | Age-and sex-adjusted Cox proportional hazards ratios with 95% confidence intervals for all-cause and cause-specific mortality. Hazard ratios as presented are adjusted for age and sex only. All hazard ratios and confidence intervals incorporate survey weights, strata, and cluster variables to obtain population estimates. Asterisks indicate statistical significance, P < 0.05. CVD, cardiovascular disease; IHD, ischemic heart disease. All-cause* CVD IHD Stroke* Cancer Figure 3 | Multivariate Cox proportional hazards ratios with 95% confidence intervals for all-cause and cause-specific mortality. Hazard ratios are adjusted for age, sex, race, education, income, physical activity, obesity, smoking, blood pressure, hyperlipidemia, diabetes, myocardial infarction, stroke, and congestive heart failure. All hazard rations and confidence intervals incorporate survey weights, strata, and cluster variables to obtain population estimates. Asterisks indicate statistical significance, P < 0.05. CVD, cardiovascular disease; IHD, ischemic heart disease. A healthy diet may improve future outcomes by affecting multiple organ systems. These effects may be additive and may be associated with lower all-cause mortality risk. Our results demonstrated an association between a DASH-like diet and lower mortality from stroke, which may be mediated by reduction in BP, as evidenced by the lower diastolic BP in the DASH-like group. Diets low in fruits, vegetables, and fiber, and high in red and processed meats have all been hypothesized to increase the risk of various cancers. 26, 27 A DASH-like diet may be associated with lower risk of colorectal adenocarcinoma in men. 28 Underlying mechanisms may include an increased concentration of phytochemicals in fruits, vegetables, and whole grains that may have antioxidant properties and may modify immune system components. 12, 29 The association of a DASH-like diet with lower plasma CRP concentrations in our and other 10 studies suggest a link between the diet and an anti-inflammatory state. Although inflammation is a component of atherogenesis, it is also a component of tumor progression; 30 as such the anti-inflammatory properties of the DASH diet may reduce the risk of cancer mortality. Though our study did not demonstrate statistically significant associations between a DASH-like diet and CVD or IHD mortality, these findings should be interpreted with caution. This was an observational study with many baseline differences between the self-selected dietary groups. Some characteristics increase the risk of CVD, although others are protective. The DASH-like group self-selected a healthier diet; cardiovascular risk factors, comorbidities, or prognostic factors unaccounted for in this analysis may have driven this self-selection process. As such, it is possible that the DASH-like group had a higher intrinsic cardiovascular risk at baseline. This may represent a variation of confounding by indication, in which individuals self-selecting a healthier diet for a particular indication may differ from the typical group with respect to baseline risk. Finally, factors intrinsic to the diet may make demonstration of a cardiovascular benefit more challenging. The DASH diet lowers BP, total cholesterol, and low-density lipoprotein cholesterol, but can also lower high-density lipoprotein cholesterol 31 and may have no effect on triglycerides; 32 low high-density lipoprotein and high triglycerides contribute to cardiovascular risk. 33, 34 The DASH-like group ate less total and saturated fats but consumed more carbohydrates and less mono-and polyunsaturated fats, which may also contribute to cardiovascular risk. 33, 35, 36 Our study had potential limitations. Some of the NHANES III data was obtained by self-report, and as such may be subject to self-report biases. Nutrient intakes were calculated from a 24-h dietary recall. Although the validity of the 24-h dietary recall has been questioned due to day-to-day variability in individuals' dietary habits, the value of the 24-h recall in assessing populations is established. 37 The DASH-like group in our study did not differ from the typical group in sodium or alcohol intake. However, this strengthens our results in that the demonstrated association between diet and all-cause mortality appears independent of sodium or alcohol intake. As NHANES III was conducted before the DASH results, our analysis does not address adherence to the diet per se, but rather demonstrates an association between consumption of a healthful diet similar to the diet recommended in the DASH trial and lower all-cause mortality. Other unaccounted confounders may contribute to the observed association. For example, NHANES III did not collect complete information on family history of CVD, an important risk factor for subsequent cardiovascular events. 38, 39 In addition, DASH-like consumers may exhibit more health-conscious behaviors than typical consumers, leading to lower mortality rates. Finally, the sample size in our study may not have been sufficiently large enough to detect an association between diet and CVD mortality. With an average follow-up time of 8.2 years for the participants in the two diet groups, and a CVD mortality rate of 13 deaths per 1,000 person-years in the typical diet group, the CVD mortality rate would have needed to be at most 7 deaths per 1,000 person-years in the 391 participants in the DASH-like group in order to have 80% power to detect a significant difference with a 5% type 1 error rate. Thus, we had 80% power to detect a hazard ratio of ≤0.54; because our observed hazard ratios for CVD mortality were 0.85 in the age-and sex-adjusted model and 0.92 in the multivariate model we were unable to detect an effect. To provide an estimate of the sample size necessary to evaluate this outcome, with an average follow-up time of 8.2 years for participants in the two diet groups and 5,141 subjects in the typical diet group, we would need ~2,700 subjects in the DASH-like diet group to obtain 80% power (with a 5% type 1 error rate) to detect a CVD mortality hazard ratio of ≤0.80 using a Cox regression model for sample survey data.
Despite these potential limitations, this analysis has several important strengths. First, this study sample provided sufficient power to detect a difference in all-cause mortality while adjusting for other covariates. Second, a population-based representative sample was surveyed, allowing estimates of usually underrepresented groups such as minorities and the elderly. Further, previous studies have predominantly sampled women; 8,10,11 our study sampled both genders. Third, data were collected using a standardized, detailed, labor-intensive process with rigorous quality control. Fourth, because data were collected in a nonmedical setting for research purposes, there was little missing data and less chance of subject response bias. Fifth, because subjects were randomly selected from different geographic regions across the country, these results are generalizable to the entire US population of adults with hypertension. Sixth, because we focused on mortality (the ultimate "hard" outcome) there is less chance that these results are spurious. Finally, participants were followed for a relatively short period, and significant temporal changes in diagnostic criteria and treatment for hypertension did not occur during this period.
In conclusion, though findings on specific causes of mortality are mixed, this analysis provides evidence that articles A DASH-Like Diet and Mortality in Hypertension consumption of a DASH-like diet is associated with lower mortality from all causes and stroke in a nationally representative sample of adults with hypertension. A DASH-like diet may potentially be associated with lower mortality from cancer, though the sample size in our study may have been too small to detect such a difference. Further research is needed to determine the utility of a DASH-like diet in reducing the risk of incident or recurrent cardiovascular events. Based on the association with lower all-cause mortality, adherence to a DASH-like diet should continue to be encouraged for all adults with hypertension.
